Comprehensive Financial Health Assessment: FINLAY HULL LIMITED

1. Financial Health Score

Grade: Pending - Insufficient Financial Data Explanation: While the company's corporate structure and compliance vitals suggest a stable baseline, a definitive financial health score cannot be assigned without access to the actual financial statements (the "blood tests" of the business). Based on the available corporate data, the structural health appears robust, but the metabolic metrics (cash flow, profitability, and solvency) require review of the filed accounts.

2. Key Vital Signs

Based on the available corporate data, we can observe the following structural vital signs:

• Corporate Heartbeat (Company Status): Active. The company is currently registered and operating, indicating a living, functioning business entity.
• Corporate Age (Longevity): Incorporated in October 2003. At over 20 years old, this is a mature organism that has survived multiple economic cycles, suggesting resilience and established market presence.
• Compliance Health (Filing Status): Accounts and Confirmation Statements are up to date and not overdue. This indicates good administrative health and adherence to regulatory hygiene.
• Genetic Makeup (Corporate Structure): The company is a Private Limited Company operating in Tea Processing (SIC 10831). It is structured as a subsidiary, claiming an audit exemption on this basis.
• Support System (Persons with Significant Control): The company is controlled by corporate entities (Finlay Extracts & Ingredients UK Limited and Finlays Solutions Limited), both owning more than 75% of shares and voting rights. This indicates the company is part of a larger corporate group, which often provides a protective "transfusion" capability in times of financial distress.

3. Diagnosis

Overall Condition: Structurally Stable, Metabolically Unknown

The available data reveals a company with a strong structural foundation. As a subsidiary of a larger corporate group, FINLAY HULL LIMITED benefits from a built-in support system. In medical terms, it is part of a larger organism; while it may have its own localized functions (tea processing), its ultimate survival is closely linked to the health of the parent group.

The current directors and the company secretary maintain the company's regulatory compliance, showing no immediate "symptoms of distress" in terms of administrative neglect. However, because the specific financial metrics—such as current assets, liabilities, and net assets—are not available in this dataset, we cannot diagnose the company's metabolic health. We cannot determine if it is suffering from "anemia" (poor cash flow) or "hypertension" (high debt burden).

4. Recommendations

To complete this diagnostic assessment and prescribe a path to optimal financial wellness, the following steps are recommended:

1. Conduct a Full Blood Panel (Obtain Filed Accounts): Acquire the full annual accounts from Companies House to review the balance sheet, profit and loss statement, and cash flow statement.
2. Examine the Umbilical Cord (Intercompany Transactions): As a subsidiary, the company's financial health is likely heavily influenced by intercompany loans, trading, and financial support from its parent companies. Review the notes to the accounts for details on these transactions.
3. Check the Parent's Health: Assess the financial wellness of the PSCs (Finlay Extracts & Ingredients UK Limited and Finlays Solutions Limited). Distress at the group level can quickly spread to the subsidiary.
4. Monitor Working Capital: Once the accounts are obtained, calculate the current ratio (current assets divided by current liabilities) to ensure the company has enough "white blood cells" to fight off short-term obligations.